What is Wockhardt Ltd (WOCKPHARMA) share price today?

Wockhardt Ltd (WOCKPHARMA) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/WOCKPHARMA for the latest live price, technical analysis, and AI-powered insights.

How to analyse WOCKPHARMA stock?

VestAI provides comprehensive WOCKPHARMA stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Wockhardt Ltd in?

Wockhardt Ltd (WOCKPHARMA) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Wockhardt Ltd

Q: What is Wockhardt Ltd's Orion Score?

Wockhardt Ltd has an Orion Score of 24/100 (Avoid) — a fundamentals-based quality & risk score. Wockhardt Ltd scores 24/100 (Avoid) on the Orion Score — poor business quality (18), weak growth (30) and weak balance-sheet safety (30). A fundamentals-based quality & risk score, not a buy/sell recommendation.

WOCKPHARMA

NSE· Healthcare

₹1,810.40

-0.30 (-0.02%)

Updated 08:47 am IST

52W Low · ₹1,086.7052W High · ₹2,150.00

Mid Range

Market Cap

₹31213.12L Cr

Volume

3.19L

Prev Close

₹1,831.30

ISIN

INE049B01025

Orion Score

Fundamentals-based quality & risk · not a recommendation

24/100

Avoid

Wockhardt Ltd scores 24/100 (Avoid) on the Orion Score — poor business quality (18), weak growth (30) and weak balance-sheet safety (30). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

—

Full Orion analysis

Risk checks

Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 6/9Altman Z Safe(4.99)Beneish M Clean(-2.64)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

85/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.42x — lean balance sheet

QUALITY

Low Quality

ROCE 5.8% — poor capital efficiency

MOMENTUM

Neutral

RSI 49.2 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 147.08
ROCE: 5.76%
ROE (1Y): 4.00%
D/E Ratio: 0.42x
OPM: 14.82%
TTM EPS: ₹13.06
Dividend Yield: 0.00%
Qtrly Sales: ₹965.00 Cr
Qtrly Profit: ₹166.00 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹965	₹166	14.8%	₹10.22
Q3 2026	₹888	₹59	12.2%	₹3.61
Q1 2026	₹738	₹-90	6.1%	₹-5.53
Q4 2025	₹743	₹-25	3.5%	₹-1.57
Q3 2025	₹721	₹14	5.7%	₹0.91

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹3,373	₹213	₹678	11.9%
FY 2025	₹3,012	₹-47	₹455	6.0%
FY 2024	₹2,789	₹-463	₹94	-1.9%
FY 2023	₹2,646	₹-559	₹-81	-5.6%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
WOCKPHARMA ★	₹31,213 Cr	147.08	5.76%	4.00%	0.42x	14.82%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹8,135	₹7,649	₹7,683	₹8,243
Equity	₹4,353	₹3,359	₹3,354	₹3,849
Total Debt	₹2,021	₹2,356	₹2,184	₹2,198
Cash	₹112	₹505	₹90	₹370
Net Debt	₹1,747	₹1,607	₹1,797	₹1,492
Working Capital	₹527	₹-607	₹-1,227	₹-618

Shareholding Pattern

Q3 FY2026

Promoter

49.09%

FII

DII

10.55%

Public

33.36%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q3 FY2026	49.09%	7% ↓	10.55% ↓	33.36% ↑
Q2 FY2026	49.09%	7.1% ↓	11%	32.79% ↑
Q1 FY2026	49.09%	7.29% ↑	11% ↑	32.6% ↓
Q4 FY2025	49.09%	6.82% ↑	10.58% ↑	33.5% ↓
Q3 FY2025	49.09% ↓	6.54% ↓	9.82% ↑	34.54% ↓
Q2 FY2025	51.99%	6.7% ↑	5.08% ↑	36.21% ↓
Q1 FY2025	51.99% ↑	5.94% ↑	4.45% ↓	37.62% ↓
Q4 FY2024	51.6%	5.49%	4.82%	38.06%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

64 mutual fund schemes

ITI Focused Fund Direct GrowthITI

4.87%

₹28 Cr

Bank of India Small Cap Fund Direct GrowthBOI_AXA

3.86%

₹89 Cr

Tata Small Cap Fund Direct GrowthTATA

3.66%

₹426 Cr

ITI Balanced Advantage Fund Direct GrowthITI

3.07%

₹11 Cr

HSBC India Export Opportunities Fund Direct GrowthHSBC

2.94%

₹35 Cr

Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct GrowthMOTILAL_OSWAL

2.79%

₹1 Cr

Tata Nifty MidSmall Healthcare Index Fund Direct GrowthTATA

2.79%

₹5 Cr

Tata Large & Mid Cap Fund Direct Plan GrowthTATA

2.55%

₹199 Cr

HDFC Pharma And Healthcare Fund Direct GrowthHDFC

2.44%

₹58 Cr

ITI Small Cap Fund Direct GrowthITI

2.41%

₹73 Cr

Analyse WOCKPHARMA with Orion AI

Ask: "Is Wockhardt Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Wockhardt Ltd (WOCKPHARMA) Stock

Wockhardt Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE049B01025. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.